A high prevalence of organ-specific autoimmunity in patients with bipolar disorder

Biological Psychiatry

Volumn 56, Issue 7, 2004, Pages 476-482

  Padmos, Roos C ^a,b   Bekris, Lynn ^b   Knijff, Esther M ^a   Tiemeier, Henning ^a   Kupka, Ralph W ^c   Cohen, Dan ^e   Nolen, Willem A ^d   Lernmark, Åke ^a,b   Drexhage, Hemmo A ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Altrecht Inst for Mental Hlth Care   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e Noordwijkerhout   (Netherlands)

Author keywords

Bipolar disorder; GAD65 autoantibodies; H K ATPase autoantibodies; sIL 2R; TPO antibodies

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA AMINO 5 TERT BUTYL 3 HYDROXY 4 ISOXAZOLEPROPIONIC ACID; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CARBOXYLYASE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; GLUTAMIC ACID; LITHIUM; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; BIPOLAR DISORDER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHIZOPHRENIA; T LYMPHOCYTE ACTIVATION;

AUTOANTIBODIES; AUTOANTIGENS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; FEMALE; GASTRITIS, ATROPHIC; GLUTAMATE DECARBOXYLASE; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; ISOENZYMES; MALE; ORGAN SPECIFICITY; PANCRELIPASE; PARIETAL CELLS, GASTRIC; RECEPTORS, INTERLEUKIN-2; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 4644250607     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.07.003     Document Type: Article

References (53)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 1994 Author Washington, DC
2. E. Barinas-Mitchell, S. Pietropaolo, Y.J. Zhang, T. Henderson, M. Trucco, L.H. Kuller, M. Pietropaolo Islet cell autoimmunity in a triethnic adult population of the Third National Health an Nutrition Examination Survey Diabetes 53 2004 1293 1302
3. F.M. Benes, M.S. Todtenkopf, P. Logiotatos, M. Williams Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain J Chem Neuroanat 20 2000 259 269
4. T. Borda, R. Perez Rivera, L. Joensen, R.M. Gomez, L. Sterin-Borda Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: Molecular interaction J Immunol 168 2002 3667 3674
5. M.N. Breunis, R.W. Kupka, W.A. Nolen, T. Suppes, K.D. Denicoff, G.S Leverich High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder Biol Psychiatry 53 2003 157 165
6. F. Cassidy, E. Ahearn, B.J. Carroll Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients Am J Psychiatry 156 1999 1417 1420
7. S.D. Chessler, A. Lernmark Alternative splicing of GAD67 results in the synthesis of a third form of glutamic-acid decarboxylase in human islets and other nonneural tissues J Biol Chem 275 2000 5188 5192
8. D.S. Cram, B. Faulkner-Jones, J. Kun, L.C. Harrison Glutamic acid decarboxylase-67 (GAD67): Expression relative to GAD65 in human islets and mapping of autoantibody epitopes Endocrinology 136 1995 1111 1119
9. A. Falorni, E. Ortqvist, B. Persson, A. Lernmark Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands J Immunol Methods 186 1995 89 99
10. M.B. First, R.L. Spitzer, M. Gibbon, J.B.W. Williams Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P) (version 2.0) 1996 Biometrics Research Department New York
11. G. Gambelunghe, F. Forini, S. Laureti, G. Murdolo, G. Toraldo, F Santeusanio Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies Clin Endocrinol 52 2000 565 573
12. P.A. Gleeson, I.A. van Driel, B.H. Toh Parietal cell autoantibodies J.B. Peter Y. Shoenfeld Autoantibodies 1996 Elsevier Science Amsterdam 600 606
13. A. Gottsäter, M. Landin-Olsson, A. Lernmark, P. Fernlund, G. Sundkvist, W.A. Hagopian Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult-onset diabetes Diabetes Res Clin Pract 27 1995 133 140
14. C.E. Grubin, T. Daniels, B. Toivola, M. Landin-Olsson, W.A. Hagopian, L Li A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM Diabetologia 37 1994 344 350
15. A. Guidotti, J. Auta, J.M. Davis, V. Di-Giorgi-Gerevini, Y. Dwivedi, D.R Grayson Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study Arch Gen Psychiatry 57 2000 1061 1069 (erratum in Arch Gen Psychiatry (2002) 59:12; DiGiorgi Gerevini V corrected to Di-Giorgi-Gerevini V)
16. C.S. Hampe, E. Ortqvist, O. Rolandsson, M. Landin-Olsson, C. Torn, A Agren Species-specific autoantibodies in type 1 diabetes J Clin Endocrinol Metab 84 1999 643 648
17. S. Heckers, D. Stone, J. Walsh, J. Shick, P. Koul, F.M. Benes Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia Arch Gen Psychiatry 59 6 2002 521 529
18. A.E. Henneberg, S. Horter, S. Ruffert Increased prevalence of antibrain antibodies in the sera from schizophrenic patients Schizophr Res 14 1994 15 22
19. M. Hornig, D.B. Goodman, M. Kamoun, J.D. Amsterdam Positive and negative acute phase proteins in affective subtypes J Affect Disord 49 1998 9 18
20. B.D. Jankovic, D. Djordjijevic Differential appearance of autoantibodies to human brain S100 protein, neuron specific enolase and myelin basic protein in psychiatric patients Int J Neurosci 60 1991 119 127
21. J. Kim, W. Richter, H.J. Aanstoot, Y. hi, Q. Fu, R Rajotte Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets Diabetes 42 1993 1799 1808
22. R.W. Kupka, M.H.J. Hillegers, W.A. Nolen, N. Breunis, H.A. Drexhage Immunological aspects of bipolar disorder Acta Neuropsychiatrica 12 2000 86 90
23. R.W. Kupka, W.A. Nolen, R.M. Post, S.L. McElroy, L.L. Altshuler, K.D Denicoff High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure Biol Psychiatry 51 2002 305 311
24. W.K. Lam-Tse, M.R. Batstra, H.J. Aanstoot, B.O. Roep, B.P.C. Koeleman, G.J. Bruining, H.A. Drexhage The association between type 1 diabetes, autoimmune thyroiditis and autoimmune gastritis Pediatr Endocrinol Rev 1 2003 23 36
25. G.S. Leverich, W.A. Nolen, A.J. Rush, S.L. McElroy, P.E. Keck, K.D Denicoff The Stanley Foundation Bipolar Treatment Outcome Network I. Longitudinal methodology J Affect Disord 67 2001 33 44
26. G.S. Leverich, R.M. Post Life charting of affective disorders CNS Spectrums 3 1998 21 37
27. S.L. Lilliker Prevalence of diabetes in a manic-depressive population Compr Psychiatry 21 1980 270 275
28. M. Maes The immune pathophysiology of major depression A. Honig H.M. Van Praag Depression: Neurobiological, Psychopathological and Therapeutic Advances 1997 Wiley & Sons London 197 215
29. M. Maes, E. Bosmans, J. Calabrese, R. Smith, H.Y. Meltzer Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers J Psychiatr Res 29 1995 141 152
30. H.M. Meinck, P.D. Thompson Stiff man syndrome and related conditions Mov Disord 17 2002 853 866
31. A.R. Mire-Sluis, R. Gaines Das, A. Lernmark The World Health Organization International Collaborative Study for islet cell antibodies Diabetologia 43 2000 1282 1292
32. J. Mohatt, L.K. Gilliam, L. Bekris, S. Ebbesson, A. Lernmark Type 1 diabetes-related autoantibodies are rare in Alaska native populations Int J Circumpolar Health 61 2002 21 31
33. M. Neufeld, N. Maclaren, R. Blizzard Autoimmune polyglandular syndromes Pediatr Ann 9 1980 154 162
34. E. Ortqvist, A. Falorni, A. Scheynius, B. Persson, A. Lernmark Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM Acta Paediatr 86 1997 1166 1171
35. J.S. Petersen, S. Russel, M.O. Marshall, H. Kofod, K. Buschard, N Cambon Differential expression of glutamic acid decarboxylase in rat and human islets Diabetes 42 1993 484 495
36. J.C. Pickup, G. Williams Chapter 12: Insulin-dependent diabetes mellitus: an overview. Textbook of Diabetes 2nd ed 1997 Blackwell Science Oxford 12.1-12.13
37. M.F. Prummel, T. Strieder, W.M. Wiersinga The environment and autoimmune thyroid diseases Eur J Endocrinol 150 2004 605 618
38. M.H. Rapaport, L. Guylai, P. Whybrow Immune parameters in rapid cycling bipolar patients before and after lithium treatment J Psychiatr Res 33 1999 335 340
39. W.T. Regenold, R.K. Thapar, C. Marano, S. Gavirneni, P.V. Kondapavuluru Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use J Affect Disord 70 2002 19 26
40. O. Rolandsson, E. Hagg, C. Hampe, E.P. Sullivan Jr, M. Nilsson, G Jansson Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index Diabetologia 42 1999 555 559
41. A.J. Rush, D.E. Giles, M.A Schlesser The Inventory of Depressive Symptomalotogy (IDS): Preliminary findings Psychiatry Res 18 1985 65 87
42. J.K. Rybakowski Antiviral and immunomodulatory effect of lithium Pharmacopsychiatry 33 2000 159 164
43. D.B. Schranz, L. Bekris, M. Landin-Olsson, C. Torn, A. Nilang, A Toll A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS) J Immunol Methods 213 1998 87 97
44. M.K. Spearing, R.M. Post, G.S. Leverich, D. Brandt, W. Nolen Modifications of the clinical global impressions scale for use in bipolar illness: The CGI-BP Psychiatry Research 73 1997 159 171
45. M. Sugiura, Y. Yokoi, S. Maruyama, T. Ishido, Y. Tokunaga, K. Sasaki Detection of anti-cerebral autoantibodies in schizophrenia and Alzheimer's disease J Clin Lab Immunol 28 1989 1 3
46. T. Suppes, G.S. Leverich, P.E. Keck, W.A. Nolen, K.D. Denicoff, L.L Altshuler The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients J Affect Disord 67 2001 45 59
47. S.Y. Tsai, K.P. Chen, Y.Y. Yang, C.C. Chen, J.C. Lee, V.K. Singh, S.J. Leu Activation of indices of cell-mediated immunity in bipolar mania Biol Psychiatry 45 1999 989 994
48. R. Uibo, E.P. Sullivan, O. Uibo, A. Lernmark, L. Salur, T. Kivik, M. Mandel Comparison of the prevalence of glutamic acid decarboxylase (GAD65) and gliadin antibodies (AGA) in a randomly selected adult estonian population Horm Metab Res 33 2001 564 567
49. C.F. Verge, D. Stenger, E. Bonifacio, P.G. Colman, C. Pilcher, P.J. Bingley, G.S. Eisenbarth Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop Diabetes 47 1998 1857 1866
50. P. Vestergaard, M. Schou Does long-term lithium treatment induce diabetes mellitus? Neuropsychobiology 17 1987 130 132
51. C. Waldner, C. Mongini, E. Alvarez, I. Roig, S.E. Hajos Inhibitory activity of soluble IL-2R in sera, ascites and culture supernatants from murine leukaemic cells Scand J Immunol 40 1994 308 316
52. I. Weets, J. Van Autreve, B.J Van der Auwera Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: Possible relation to increased body mass index Diabetologia 44 2001 40 47
53. R.C. Young, J.T. Biggs, V.E. Ziegler A rating scale for mania; reliability, validity and sensitivity Br J Psychiatry 133 1978 429 435